Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  OTC Bulletin Board  >  Applied DNA Sciences Inc    

SummaryNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Applied DNA Sciences Inc : Applied DNA Sciences Continues Expansion in Sweden

share with twitter share with LinkedIn share with facebook
share via e-mail
0
12/11/2012 | 04:40am CEST
Applied DNA Sciences Continues Expansion in Sweden Security Giant Nokas Adopts DNA Evidentiary Marking

MEDIA CONTACT: Mitchell Miller, 646-543-3373, fax: 631-444-8848

INVESTOR CONTACT: Debbie Bailey, 631-444-8090, fax: 631-444-8848

FCMN Contact: info@adnas.com

PROGRAM CONTACT: Leif Svensson, CEO, Safe Solution AB, +46 76-774 44 14

Web site: http://www.adnas.com

Twitter: @APDN, @APDNInvestor

STONY BROOK, NY, December 10, 2012. Applied DNA Sciences, Inc. (OTC Bulletin Board: APDN), (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology and product authentication solutions, announced today that its evidentiary DNA platform has been adopted in Sweden for use in helping protect cash in transit in that country. The security company Nokas AS revealed that APDN's marking and authentication

platform will first be deployed in armored vehicles in the Stockholm area and then expanded to the company's
entire fleet.
The technology comes into play during a robbery, when botanically-based DNA marks within a water-based spray are released on cash notes and the criminals themselves. The marks can survive on the notes, clothes, and skin for long periods of time. In court, they provide accepted evidence directly linking criminals to the crime.
Nokas, based in Norway, fields a fleet of over 250 armored trucks to transport cash. It is one of only two cash transport companies in Sweden servicing many retail chains, large banks and other institutions.
The APDN platform for cash in transit already has been used with great success in the United Kingdom, where DNA evidence has helped in over fifty convictions of armed and dangerous criminals since 2009, in an environment where front-line police and private guards are typically unarmed. The DNA marking and authentication platform protects more than 26% of cash being transported to and from banks in the United Kingdom.
Johan Petersson, Nokas security officer, commented, "This is an exciting development for the entire security industry. We are the first with new technology in cash in transit in this region, which helps deter crime and helps the judiciary to prosecute any offense. Using this new technology, Nokas will provide added security to its staff and customers. We believe we are at the forefront."
Elsewhere in Sweden, adoption of the APDN DNA platform has been expanding.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on APPLIED DNA SCIENCES INC
08/10 APPLIED DNA SCIENCES : reports 3Q loss
08/10 APPLIED DNA SCIENCES, INC. (NASDAQ : APDN) Files An 8-K Results of Operations an..
08/10 APPLIED DNA SCIENCES INC : Results of Operations and Financial Condition, Financ..
08/10 APPLIED DNA SCIENCES : Management's Discussion and Analysis of Financial Conditi..
08/10 APPLIED DNA SCIENCES : Reports Fiscal Third Quarter 2017 Financial Results
08/10 APPLIED DNA SCIENCES INC : Investor Network: Applied DNA Sciences, Inc. to Host ..
08/10 APPLIED DNA SCIENCES : to Begin Production Testing with Major US-based Bearings ..
08/10 APPLIED DNA SCIENCES : to Begin Production Testing with a Major US-Based Bearing..
08/08 APPLIED DNA SCIENCES : Completes Large-Scale Molecular Tagging of Fertilizer Suc..
07/28 APPLIED DNA SCHEDULES FISCAL 2017 TH : 30 pm et
More news
Financials ($)
Sales 2017 6,63 M
EBIT 2017 -11,4 M
Net income 2017 -10,1 M
Debt 2017 -
Yield 2017 -
P/E ratio 2017 -
P/E ratio 2018
Capi. / Sales 2017 8,25x
Capi. / Sales 2018 4,72x
Capitalization 54,8 M
Income Statement Evolution
Consensus
 
Mean consensus OUTPERFORM
Number of Analysts 1
Average target price 5,00 $
Spread / Average Target 150%
EPS Revisions
Managers
NameTitle
James A. Hayward Chairman, President & Chief Executive Officer
Beth Jantzen Chief Financial Officer & Controller
Ming-Hwa Benjamin Liang Secretary & Chief Scientific Officer
Judith Murrah Chief Information Officer
Sanford R. Simon Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
APPLIED DNA SCIENCES INC55
ECOLAB INC.11.10%37 686
SIKA37.26%15 142
SYMRISE7.21%9 445
CLARIANT26.47%7 643
JOHNSON MATTHEY PLC-11.44%7 032